Vienna Biocenter

{{Short description|Group of life science research institutes in Vienna, Austria}}

File:Campus-Vienna-Biocenter-01-.jpg

File:Campus-Vienna-Biocenter-02-.jpg

File:Campus-Vienna-Biocenter-03-.jpg

The Vienna BioCenter is a cluster of life science research institutes and biotechnology companies located in the 3rd municipal District of Vienna, Austria. It grew around the Research Institute of Molecular Pathology (IMP), which opened in 1988. The entities at the Vienna BioCenter employ more than 2,000 people, including 600 students.{{cite web | last=Austria | first=Regionalmedien | title=Biotechnologie: Die Zellversteher von Sankt Marx | website=meinbezirk.at | date=2017-07-07 | url=https://www.meinbezirk.at/land-oesterreich/wirtschaft/biotechnologie-die-zellversteher-von-sankt-marx-d2174738.html | language=de | access-date=2017-12-20}}{{cite journal | last=Tebb | first=Graham | title=Vienna landmark | journal=Current Biology | publisher=Elsevier BV | volume=18 | issue=12 | year=2008 | issn=0960-9822 | doi=10.1016/j.cub.2008.06.009 | pages=R499–R500| doi-access=free }}

Structure

As of 2020, the Vienna BioCenter is an association of six research entities, 38 biotech companies, 1 outreach organisation, 4 service companies and 2 business incubators.{{citation needed|date=February 2018}}

There are four basic research institutes on campus: the Research Institute of Molecular Pathology (IMP), the Max Perutz Labs of the University of Vienna and Medical University of Vienna, the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences (ÖAW), and the Gregor Mendel Institute of Molecular Plant Biology (GMI), also of the ÖAW.{{cite journal | title=Spotlight on Austria | journal=Nature Jobs | publisher=Springer Nature | date=2014-04-23 | issn=1476-4687 | doi=10.1038/nj0422 }} These institutes maintain a joint international PhD programme.{{cite web | title=PhD PROGRAMME | website=Vienna Biocenter PhD Programme | url=https://www.training.vbc.ac.at/phd-programme/ | access-date=2017-12-20}} The University Biology Building (UBB) houses parts of the Faculty of Life Sciences and the Centre for Microbiology and Environmental Systems Science (CeMESS), both part of the University of Vienna.

In September 2024, the Boehringer Ingelheim Stiftung and Austrian Academy of Sciences (ÖAW) incepted the Aithyra Institute, a research organisation for Artificial intelligence and biomedicine.{{Cite web |title=Announcement of the inception of Aithyra Institute. |url=https://www.boehringer-ingelheim-stiftung.de/en/what-we-fund/funding-initiatives/aithyra-institute.html |access-date=8 October 2024 |website=Boehringer Ingelheim Stiftung}}

The "[https://www.viennabiocenter.org/vbcf/ Vienna BioCenter Core Facilities]" (VBCF) offer central services, largely scientific, but also including a child care centre.{{cite web|url=http://www.vbcf.ac.at/home/|publisher=vbcf.ac.at|title=VBCF | Home|date=2017-07-07|access-date=2017-07-12}}

Awards

Kim Nasmyth, emeritus director of the Research Institute of Molecular Pathology (IMP), currently at the University of Oxford, received the 2018 Breakthrough Prize in Life Sciences for his work on chromosome segregation.{{cite web | title=Kim Nasmyth: Glücklicher Held einer Wiener Erfolgsgeschichte | website=DER STANDARD | date=2018-02-10 | url=https://www.derstandard.de/story/2000073805924/kim-nasmyth-gluecklicher-held-einer-wiener-erfolgsgeschichte | language=de | access-date=2018-02-18}}{{cite web | title=Breakthrough Prize awarded to Kim Nasmyth | website=The Research Institute of Molecular Pathology | date=2017-12-04 | url=https://www.imp.ac.at/news/detail/article/breakthrough-prize-awarded-to-kim-nasmyth/ | access-date=2018-02-18}}

After receiving the 2015 Breakthrough Prize in Life Sciences, the 2020 Nobel Prize for Chemistry was awarded to Emmanuelle Charpentier and Jennifer Doudna for their groundbreaking discoveries on the CRISPR/Cas9 system. Emmanuelle Charpentier was a principal investigator at the Max Perutz Labs at the University of Vienna from 2002 to 2009, where she laid the groundwork for developing the technology.

As of May 2021, scientists of the Vienna BioCenter institutes have been awarded 57 ERC grants and eleven Wittgenstein Awards.{{cite web | author=Presse-Service | title=Archivmeldung: Angebot komplettiert: Erste Start-up Labs für Wiener Life Science-Branche | website=Presseservice der Stadt Wien | date=2017-05-03 | url=https://www.wien.gv.at/presse/2017/05/03/angebot-komplettiert-erste-start-up-labs-fuer-wiener-life-science-branche | language=de | access-date=2017-12-20}}

References

{{reflist|2}}